Brompton Funds Limited · TSX
| Assets under management | $65.32M |
|---|---|
| Expense ratio | — |
| Category | — |
| Dividend yield | 8.95% |
| NAV | $7.40 |
| Fund family | Brompton Funds Limited |
| Exchange | TSX |
The largest positions Brompton Global Healthcare Income & Growth ETF reports, by weight.
| Holding | Name | Weight |
|---|---|---|
| JNJ | Johnson & Johnson | 5.83% |
| NVS | Novartis AG ADR | 5.59% |
| LLY | Eli Lilly and Co | 5.44% |
| CAH | Cardinal Health Inc | 5.42% |
| UNH | UnitedHealth Group Inc | 4.87% |
| GILD | Gilead Sciences Inc | 4.67% |
| VRTX | Vertex Pharmaceuticals Inc | 4.57% |
| BMY | Bristol-Myers Squibb Co | 4.54% |
| A | Agilent Technologies Inc | 4.36% |
| MRK | Merck & Co Inc | 4.32% |